Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis-Reference-Cited by-同舟云学术

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis

Published:2022-08-16 Issue:12 Volume:24 Page:2355-2363
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Patel Rishi K.¹^ORCID,Ioannou Adam¹,Razvi Yousuf¹,Chacko Liza¹,Venneri Lucia¹,Bandera Francesco²³,Knight Daniel¹,Kotecha Tushar¹,Martinez‐Naharro Ana¹,Masi Ambra¹,Porcari Aldostefano¹⁴,Brown James¹,Patel Kiara¹,Manisty Charlotte⁵,Moon James⁵,Rowczenio Dorota¹,Gilbertson Janet A.¹,Sinagra Gianfranco⁴,Lachmann Helen¹,Wechalekar Ashutosh¹,Petrie Aviva⁶,Whelan Carol¹,Hawkins Philip N.¹,Gillmore Julian D.¹,Fontana Marianna¹

Affiliation:

1. National Amyloidosis Centre, Division of Medicine University College London London UK

2. Heart Failure Unit, Cardiology University Department IRCCS Policlinico San Donato Milan Italy

3. Department for Biomedical Sciences for Health University of Milano Milan Italy

4. Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department Azienda Sanitaria Universitaria Giuliano‐Isontina (ASUGI), University of Trieste Trieste Italy

5. Barts Heart Centre, The Cardiovascular Magnetic Resonance Imaging Unit, and the Inherited Cardiovascular Diseases Unit St Bartholomew's Hospital London UK

6. Eastman Dental Institute, University College London London UK

Funder

British Heart Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2646

Reference26 articles.

1. Transthyretin Amyloid Cardiomyopathy

2. Systemic amyloidosis